Table 2.
MicroRNAs CpG sites differentially methylated in Alzheimer's disease.
| CpG probe ID | Chr: Start site | Associated gene | UCSC_RefGene_Group | Relation_to_CpG_Island | Enhancer | Control | AD | Delta beta | p value |
|---|---|---|---|---|---|---|---|---|---|
| cg22806002 | 11: 111383083 | BTG4; MIR34C; MIR34B | TSS200; TSS1500; TSS1500 | N_Shore | — | 0.314 ± 0.005 | 0.358 ± 0.008 | 0.044 (4.4%) | 0.0015 |
| cg13149127 | 1: 156390835 | C1orf61; MIR9-1 | 5′UTR; TSS1500 | Island | TRUE | 0.045 ± 0.001 | 0.055 ± 0.002 | 0.010 (1%) | 0.0015 |
| cg09994773 | 1: 9212514 | MIR34A | TSS1500 | “open sea” | — | 0.826 ± 0.008 | 0.867 ± 0.011 | 0.041 (4.1%) | 0.0057 |
| cg16865908 | 11: 121970496 | LOC399959; MIR125B1 | Body; Body | “open sea” | TRUE | 0.068 ± 0.007 | 0.109 ± 0.015 | 0.040 (4.0%) | 0.0101 |
| cg25851152 | 10: 10419537 | MIR146B | TSS1500 | S_Shelf | TRUE | 0.072 ± 0.002 | 0.084 ± 0.002 | 0.011 (1.1%) | 0.0101 |
| cg09148270 | 11: 111384223 | BTG4; C11orf88; MIR34C | TSS1500; TSS1500; Body | N_Shore | — | 0.315 ± 0.010 | 0.372 ± 0.018 | 0.056 (5.6%) | 0.0172 |
| cg14278808 | 8: 9761141 | LOC157627; MIR124-1 | TSS1500; TSS200 | Island | — | 0.042 ± 0.002 | 0.051 ± 0.002 | 0.009 (0.9%) | 0.0220 |
| cg10822545 | 19: 13985513 | MIR181D; MIR181C | TSS200; Body | S_Shore | — | 0.833 ± 0.009 | 0.864 ± 0.007 | 0.031 (3.1%) | 0.0220 |
| cg02315626 | 17: 27188560 | MIR451; MIR144 | TSS200; Body | “open sea” | — | 0.802 ± 0.011 | 0.841 ± 0.011 | 0.038 (3.8%) | 0.0220 |
| cg12530503 | 15: 89911148 | MIR9-3 | TSS200 | Island | TRUE | 0.129 ± 0.005 | 0.153 ± 0.007 | 0.024 (2.4%) | 0.0349 |
AD = Alzheimer's disease; beta values are presented as means ± SEM; delta beta is the average of DNA methylation difference between the two compared groups; Mann-Whitney test, p values refer to the statistical analysis of the means of methylation levels from the two compared groups.